Literature DB >> 25876216

First isolation of Coxiella burnetii from clinical material by cell-free medium (ACCM2).

K Boden1, K Wolf, B Hermann, D Frangoulidis.   

Abstract

A disadvantage in Q fever diagnostics and research is the insensitive and difficult culture of Coxiella burnetii. This intracellular organism can only be isolated using embryonated eggs, animal hosts, or mammalian cell culture. In consequence, it has only been possible to isolate a few strains from human patients. Here, we describe the first isolation of C. burnetii from a clinical specimen using the recently developed cell-free medium acidified citrate cysteine medium 2 (ACCM2). We screened the sera of 217 patients who had undergone valvular transplantation but detected one serum with an antibody constellation indicating chronic Q fever. Polymerase chain reaction (PCR) of the corresponding heart valve revealed 3.1 × 10(5) copies/rxn. The strain was successfully isolated using ACCM2. Genomic investigation by multilocus variable-number of tandem repeat (VNTR) analysis (MLVA) revealed the strain to be a new genotype, A10, closely related to one from sheep. As the sensitivity of ACCM2 for different human strains is unknown, we also investigated combining a robust test, egg propagation, with ACCM2. This combination produced four to six logs of growth of the bacteria. The use of ACCM2 in this combination simplified the otherwise elaborate purification steps. Cultivation in ACCM2 has the potential to simplify the isolation of C. burnetii in a clinical setting. As the success rates of cell culture for virulent C. burnetii strains are variable, the sensitivity of ACCM2 for different strains is unknown, and many specimens may contain much fewer bacteria than in our case, the combination of the robust method of egg propagation with ACCM2 is a good alternative to existing single methods for investigating critical specimens.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25876216     DOI: 10.1007/s10096-015-2321-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

Review 1.  Axenic growth of Coxiella burnetii.

Authors:  Anders Omsland
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Risks factors and prevention of Q fever endocarditis.

Authors:  F Fenollar; P E Fournier; M P Carrieri; G Habib; T Messana; D Raoult
Journal:  Clin Infect Dis       Date:  2001-06-25       Impact factor: 9.079

3.  Host cell-free growth of the Q fever bacterium Coxiella burnetii.

Authors:  Anders Omsland; Diane C Cockrell; Dale Howe; Elizabeth R Fischer; Kimmo Virtaneva; Daniel E Sturdevant; Stephen F Porcella; Robert A Heinzen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

4.  Use of shell-vial cell culture assay for isolation of bacteria from clinical specimens: 13 years of experience.

Authors:  Frédérique Gouriet; Florence Fenollar; Jean-Yves Patrice; Michel Drancourt; Didier Raoult
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Virulence of pathogenic Coxiella burnetii strains after growth in the absence of host cells.

Authors:  Gilbert J Kersh; Lindsay D Oliver; Joshua S Self; Kelly A Fitzpatrick; Robert F Massung
Journal:  Vector Borne Zoonotic Dis       Date:  2011-08-25       Impact factor: 2.133

6.  Laboratory maintenance of Coxiella burnetii.

Authors:  James E Samuel; Laura R Hendrix
Journal:  Curr Protoc Microbiol       Date:  2009-11

7.  Molecular analysis of Coxiella burnetii in Germany reveals evolution of unique clonal clusters.

Authors:  Dimitrios Frangoulidis; Mathias C Walter; Markus Antwerpen; Pia Zimmermann; Britta Janowetz; Michaela Alex; Jens Böttcher; Klaus Henning; Angela Hilbert; Martin Ganter; Martin Runge; Martin Münsterkötter; Wolf D Splettstoesser; Matthias Hanczaruk
Journal:  Int J Med Microbiol       Date:  2014-06-27       Impact factor: 3.473

8.  Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components.

Authors:  J C Williams; M G Peacock; T F McCaul
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

9.  The use of polymerase chain reaction to detect septicemia in critically ill patients.

Authors:  R T Cursons; E Jeyerajah; J W Sleigh
Journal:  Crit Care Med       Date:  1999-05       Impact factor: 7.598

Review 10.  Changing epidemiology of Q fever in Germany, 1947-1999.

Authors:  W Hellenbrand; T Breuer; L Petersen
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

View more
  3 in total

Review 1.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Genotyping and Axenic Growth of Coxiella burnetii Isolates Found in the United States Environment.

Authors:  Gilbert J Kersh; Rachael A Priestley; Heidie M Hornstra; Joshua S Self; Kelly A Fitzpatrick; Brad J Biggerstaff; Paul Keim; Talima Pearson; Robert F Massung
Journal:  Vector Borne Zoonotic Dis       Date:  2016-06-15       Impact factor: 2.133

3.  Spinning sugars in antigen biosynthesis: characterization of the Coxiella burnetii and Streptomyces griseus TDP-sugar epimerases.

Authors:  Alice R Cross; Sumita Roy; Mirella Vivoli Vega; Martin Rejzek; Sergey A Nepogodiev; Matthew Cliff; Debbie Salmon; Michail N Isupov; Robert A Field; Joann L Prior; Nicholas J Harmer
Journal:  J Biol Chem       Date:  2022-04-06       Impact factor: 5.486

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.